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Diapedesis is critical for immune system func-
tion and inflammatory responses. This occurs
by migration of blood leukocytes either directly
through individual microvascular endothelial
cells (the ‘‘transcellular’’ route) or between
them (the ‘‘paracellular’’ route). Mechanisms
for transcellular pore formation in endothelium
remain unknown. Here we demonstrate that
lymphocytes used podosomes and extended
‘‘invasive podosomes’’ to palpate the surface
of, and ultimately form transcellular pores
through, the endothelium. In lymphocytes,
these structures were dependent on Src kinase
and the actin regulatory protein WASP; inhibi-
tion of podosome formation selectively blocked
the transcellular route of diapedesis. In endo-
thelium, membrane fusion events dependent
on the SNARE-containing membrane fusion
complex and intracellular calciumwere required
for efficient transcellular pore formation in
response to podosomes. These findings
provide insights into basic mechanisms for
leukocyte trafficking and the functions of
podosomes.
INTRODUCTION
Whereas functions for most cells of the body are coupled
to their organization in tissues, functions for blood leuko-
cytes are uniquely centered on their ability to efficiently
cross tissue barriers, i.e., invasiveness. In order to conduct
immune surveillance, respond to infection, and undergo
differentiation, leukocytes must traffic throughout the
body, moving in and out of the bone marrow, lymphoid
organs, and inflamed tissues (von Andrian and Mackay,
2000). A central component to this process is the repeated
crossing of vascular and lymphatic endothelial barriers,
i.e., diapedesis, as leukocytes leave and re-enter the circu-784 Immunity 26, 784–797, June 2007 ª2007 Elsevier Inc.lation (von Andrian and Mackay, 2000). Fundamental
aspects of the mechanisms for this barrier-crossing func-
tion remain unknown.
Diapedesis occurs in vivo either directly through individ-
ual endothelial cells (the transcellular route) or between
them at interendothelial cell junctions (the paracellular
route) (Feng et al., 1998; Greenwood et al., 1994; Lossin-
sky and Shivers, 2004; Marchesi, 1961; Marchesi and
Gowans, 1963). In both cases, the process begins with
the accumulation of leukocytes on the luminal surface of
the endothelium through a well-characterized sequence
of rolling, activation, and firm adhesion events (Springer,
1994). Subsequent integrin-dependent lateral migration
is an essential next step that seems to allow leukocytes
to search out sites permissive for endothelial barrier
penetration (Schenkel et al., 2004). The final and critical
steps of identifying such sites and then formally breaching
the endothelium are incompletely understood.
Interendothelial cell junctions provide a defined and
intuitive site for paracellular diapedesis, and mechanistic
models for this process have been proposed (Muller,
2003). In contrast, neither an intuitive locus nor an obvious
mechanism for transcellular diapedesis exists. Whatever
the mechanism, transcellular diapedesis requires, at
minimum, local displacement of endothelial cytoplasmic
organelles and fusion of the apical and basal plasma
membranes. Formally, this process could be driven by
the leukocyte, by the endothelium, or by contributions
from both.
On the part of the leukocyte, actin-dependent protru-
sive structures might be able to both displace endothelial
organelles and facilitate membrane fusion by forcing
apical and basal membranes into close opposition. Candi-
date protrusive structures include the well-characterized
filopodia, lamellipodia, and related pseudopodia (Ridley
et al., 2003), along with more recently discovered protru-
sive organelles termed podosomes (‘‘foot-protrusions’’)
and invadopodia (Buccione et al., 2004; Linder and
Aepfelbacher, 2003; Yamaguchi et al., 2005b).
Podosomes and invadopodia are micron-scale cylindri-
cal protrusions formed on the ventral aspect of adherent
cells with the defining architecture of a peripheral ring of
b2 or b3 integrin, talin, and vinculin, and a central core of
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2003). These protrusive structures share a strong depen-
dence on Src kinase and the cytoskeletal regulator
Wiskott-Aldrich syndrome (WAS) protein (WASP) or
N-WASP in nonhematopoietic cells (Calle et al., 2004;
Linder and Aepfelbacher, 2003). Distinction between
podosomes and invadopodia are seen in their size (with
substantially greater protrusion depths observed in inva-
dopodia), dynamics, and apparent functions (Buccione
et al., 2004; Yamaguchi et al., 2005b). Podosomes have
been described in a wide range of migratory cell types,
most notably leukocytes, where they form dynamic clus-
tered arrays or ‘‘rosettes’’ (Buccione et al., 2004; Evans
et al., 2003; Linder and Aepfelbacher, 2003). However,
their function is unclear, though generally linked to adhe-
sion and migration. In contrast, invadopodia, which have
been described only in transformed cell types, have
a more defined function in burrowing across matrix
barriers, thereby conferring invasiveness to metastatic
tumor cells (Buccione et al., 2004; Yamaguchi et al.,
2005a).
An active role for the endothelium during diapedesis has
been widely demonstrated through, for example, leuko-
cyte-triggered calcium and Rho signaling (Adamson
et al., 1999; Carman and Springer, 2004; Etienne-Manne-
ville et al., 2000; Huang et al., 1993; Muller, 2003). We and
others have previously hypothesized that such intraendo-
thelial signals could potentially trigger membrane fusion
events that facilitate transcellular pore formation (Carman
and Springer, 2004; Feng et al., 2002; Lossinsky and
Shivers, 2004; Olah and Glick, 1985).
Here we demonstrate that leukocytes dynamically
inserted numerous podosomes and extended ‘‘invasive
podosomes,’’ the latter of which exhibit similarities to
invadopodia, into the endothelial surface both in vitro
and in vivo. This serves to probe for sites permissive to
transcellular pore formation and to trigger endothelial
fusion activity that supports this process. This previously
unrecognized palpation behavior was critical for transcel-
lular diapedesis and may also play broader roles in leuko-
cyte path finding during trafficking.
RESULTS
Transcellular Diapedesis Is Quantitatively Important
in Microvascular Endothelium
Given that the vast majority of leukocyte traffic in vivo
occurs through the microvasculature (von Andrian and
Mackay, 2000), in this study we investigated migration
on human dermal (HDMVEC) and lung (HLMVEC) micro-
vascular endothelial monolayers. By using our previously
established fixed-cell imaging approach (Carman and
Springer, 2004) with IL-2-cultured lymphocytes, we
demonstrate that approximately one-third of diapedesis
events occurred via the transcellular route on tumor
necrosis factor (TNF)-a-activated HDMVEC and HLMVEC
(Figure 1A). We also examined and found comparable
results for dermal lymphatic endothelium (Figure 1A). By
contrast, approximately 10% of lymphocytes transmi-grated via the transcellular route on HUVEC (human
umbilical vein endothelial cells), a phenotypically distinct
macrovascular endothelium (Figure 1A; Carman and
Springer, 2004). Dynamic live-cell imaging experiments
showed that the kinetic parameters of para- and transcel-
lular diapedesis are largely indistinguishable (Figure 1B).
This confirmed the validity of using a fixed-cell, single-
time-point analysis for quantitative comparison of para-
and transcellular diapedesis.
We attempted to selectively block paracellular diapede-
sis. Paracellular diapedesis is predicted to be uniquely
dependent on molecules enriched at the endothelial
junctions including platelet-endothelial cellular adhesion
molecule-1 (PECAM-1), junctional adhesion molecule-1
(JAM-1), and CD99 (Muller, 2003). Thus, we employed
a widely used PECAM-1 function-blocking antibody
(HEC7) (Muller, 2003). To our surprise, we found that
although HEC7 inhibited diapedesis, it affected both
para- and transcellular routes comparably (Figure 1C).
Immunofluorescence imaging of PECAM-1 (Figure 1D)
and JAM-1 (Figure S1 in the Supplemental Data available
with this article online) showed that these molecules were
similarly enriched around both trans- and paracellular
diapedesis events in previously described ‘‘transmigra-
tory cups’’ (Barreiro et al., 2002; Carman and Springer,
2004). Though the role of PECAM-1 in lymphocyte
diapedesis in vivo remains unclear, these data suggest
that PECAM-1 and JAM-1 may not be specific for paracel-
lular transmigration.
Clusters of Dynamic, Micron-Scale Invaginations
into the Endothelial Surface Precede
Transcellular Diapedesis
Live-cell imaging experiments, combining fluorescence
and DIC (differential interference contrast) modalities,
were used to dissect mechanisms for transcellular
diapedesis. To monitor the endothelial cell-surface
dynamics, we imaged lymphocyte migration on micro-
vascular endothelial cells transfected with intercellular
adhesion molecule (ICAM)-1 fused to GFP (ICAM-1-
GFP). Lymphocytes migrated laterally over the endothe-
lium and underwent both trans- and paracellular diapede-
sis. Strikingly, clusters of micron-scale fluorescent rings
(0.2–1 mm in diameter) formed intermittently under
most spread and laterally migrating lymphocytes (Figure 2
and Movie S1). The initial appearance of a single or several
rings was typically followed by the rapid (within 30 s)
appearance of clusters containing 10–30 rings (covering
an area of 100 mm2) as lymphocytes spread (Figure 2).
For laterally migrating lymphocytes, rings formed predom-
inantly just behind the leading edge (see Movie S3) but
also formed under the trailing edges and various lateral
extensions (see below and Movie S9). Individual rings
were highly dynamic and appeared, disappeared, and
changed size and shape on the time scale of tens of sec-
onds (Figure 2).
Most importantly, formation of transcellular pores at the
initiation of transcellular diapedesis was essentially
always preceded by the appearance of rings (Figure 2Immunity 26, 784–797, June 2007 ª2007 Elsevier Inc. 785
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(A) IL-2-cultured lymphocytes were incubated with TNF-a-activated endothelial monolayers for 10 min followed by fixation, staining, and scoring as
described in Experimental Procedures. Endothelial cells included HDMVEC and HLMVEC from Cambrex, as well as HDMVEC (HDMVEC*) and
lymphatic ECs (Lymph*) selectively isolated from fresh neonatal foreskins. y axis represents the percentage of the total diapedesis that was trans-
cellular. Values are mean ± SEM for at least three separate experiments.
(B) Videos from live-cell imaging of lymphocyte diapedesis on HDMVEC and HLMVEC (described in Figure 2, below) were analyzed to determine the
total duration of diapedesis and the amount of time lymphocytes resided at a location before initiating diapedesis (dwell time) for transcellular (black
bars) or paracellular (gray bars) events. Data for the HLMVECs (L) and HDMVECs (D) were analyzed both separately and together (T). Values are the
mean ± SEM for at least seven measurements.
(C) Lymphocytes were incubated with activated HLMVEC as in (A) above, in the absence (gray bars) and presence (black bars) of PECAM-1 function-
blocking mAb HEC7 (40 mg/ml). Graph depicts total diapedesis, as well as the separate the para- and transcellular diapedesis components, each as
a percentage of total cells. Values are the mean ± SEM of three separate experiments. 40 or 120 mg/ml isotype control antibody had no effect on
diapedesis (not shown).
(D) Lymphocytes were incubated with activated HLMVEC for 10 min followed by fixation and staining with fluorescent antibodies to integrinb2, ICAM-1,
and PECAM-1 and subjected to confocal microscopy. Images are Z-stack projections of representative transcellular (left) and paracellular (right)
diapedesis events. Note that under one of the two lymphocytes on the left, two transcellular pores have formed. Arrows indicate the PECAM-1-
enriched interendothelial junctions. Scale bar represents 5 mm.and Movie S1). An analysis of 58 transcellular diapedesis
events from representative videos demonstrated that
as few as 4 and as many as 216 rings (average ± SEM =
62.1 ± 7.1) were seen prior to the formation of each
transcellular pore. In most cases, the initial pores wid-
ened rapidly (expanding their diameter an average786 Immunity 26, 784–797, June 2007 ª2007 Elsevier Inc.rate ± SEM = 2.6 ± 0.2 mm/min; n = 28) to a maximum
of 6 mm, as lymphocyte diapedesis proceeded, and then
constricted and resealed (Movie S1). These observations
suggested a potential functional relationship between
the ring-shaped structures and the initiation of transcellu-
lar diapedesis.
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Micron-Scale ICAM-1-Rich Rings on the Endothelium
TNF-a-activated HDMVEC transiently transfected with ICAM-1-GFP
were subjected to live-cell dynamic imaging upon addition of lympho-
cytes as described in Experimental Procedures. (A) and (C) are DIC,
and (B), (D), and (E) are fluorescence images of ICAM-1-GFP. (A) and
(B) depict a wide field of view in which most of a single GFP-positive
endothelial cell (in the context of a confluent endothelial monolayer)
is present. Boxed regions in (A) and (B) depict a location distant fromTo determine whether the observed structures repre-
sented planar rings of ICAM-1-GFP enrichment or
involved topological perturbations in the endothelial
membrane, we conducted analyses similar to those above
by using, instead of ICAM-1-GFP, palmitoylated YFP
(memb-YFP) as a general membrane marker. This mem-
brane reporter revealed essentially identical ring-shaped
structures, with dynamics and association with transcellu-
lar pores similar to those seen with ICAM-1-GFP (Movies
S2 and S3), demonstrating that the ‘‘rings’’ represented
topological changes in the endothelial membrane surface.
We reasoned that the fluorescent rings could arise from
either apical exvaginations or invaginations of the endo-
thelial plasma membrane. To distinguish between these
possibilities, endothelial cells were cotransfected with pal-
mitoylated RFP (memb-RFP) as a membrane marker and
unmodified GFP as a marker for the cytoplasmic volume.
Live-cell imaging demonstrated a striking inverse correla-
tion between memb-RFP rings and GFP distribution:
within each memb-RFP ring, the GFP signal was dimin-
ished (Figure 3A, Movies S4 and S8; see below). This
suggests that the ring-shaped membrane structures rep-
resent invaginations of the apical endothelial membrane.
To probe this idea further, we investigated the distribu-
tion of other intracellular components in endothelium.
Endoplasmic reticulum (Endotracker-Green [Figure 3B
and Movie S5]), GFP-actin (Movie S6), and GFP-tubulin
(Movie S7) were also displaced and distorted at sites of
ring formation. Rings also formed directly over the nucleus;
however, there was little apparent distortion of this organ-
elle and never transcellular pore formation at this site
(Movies S3 and S8).
Endothelial Invaginations Result from Podosome-
like Leukocyte Protrusions
To determine the role of the leukocyte and endothelium in
the formation of the invaginations, we employed K562
cells, which lack protrusive activity (Carman et al., 2003).
K562 LFA-1 transfectants, which were activated with
a mAb to lymphocyte function-associated antigen (LFA)-1,
elicited formation of ICAM-1-enriched cup-like structures
on HDMVEC, but not ring-shaped invaginations or transcel-
lular pores (data not shown). In contrast, SDF-1-stimulated
lymphocytes readily induced ring-shaped invaginations,
and occasionally transcellular pores, on CHO-K1 epithelial
cells stably expressing ICAM-1-GFP (Figure S2A). These
endothelial intercellular junctions. Columns (C), (D), and (E) depict
expanded sequential views (at 14 s intervals) of these boxed regions,
in which the right-most lymphocyte initiates transcellular diapedesis.
The micrographs shown in column (E) are identical to those shown in
column (D), but individual ICAM-1-GFP-rich ring-shaped structures
have been highlighted, with distinct colors correlating to each time
point. (F) represents the overlay of these lines. Note that formation of
a transcellular pore (see arrows in [D] and [E] at the 84 s time point),
through which the lymphocyte subsequently completes transcellular
diapedesis (shown in Movie S1), emerges from the center of two of
these rings, which appear to fuse. Scale bars represent 5 mm.Immunity 26, 784–797, June 2007 ª2007 Elsevier Inc. 787
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Podosomes Initiate Transcellular DiapedesisFigure 3. ‘‘Ring Structures’’ Represent Endothelial Cell-Surface Invaginations
TNF-a-activated HLMVEC were subjected to live-cell dynamic imaging upon addition of lymphocytes.
(A) HLMVEC were transiently cotransfected with memb-RFP and unmodified GFP. Panels depict DIC, memb-RFP, GFP, and merge of memb-RFP
and GFP. Upper panels show a time point shortly after lymphocytes have settled on the endothelium, but before formation of memb-RFP ring struc-
tures (relative time = 0 s). Lower panels show a time point after lymphocyte spreading and formation of rings (relative time 170 s). Note that for each
memb-RFP ring, a circular region of diminished GFP signal is formed. See corresponding Movie S4.
(B) HDMVEC were transiently transfected with memb-RFP and prestained with ER-tracker green. Panels depict DIC, memb-RFP, ER-tracker green,
and Merge of memb-RFP and ER-tracker green. Upper panels show a time point before (relative time = 0 s) and lower panels show a time point after
(relative time 460 s) the formation of memb-RFP ring structures. Note that memb-RFP ring structures seem to form within the individual reticula of the
ER often distorting and expanding these structures. These features can be more readily appreciated in the corresponding Movie S5. Scale bars
represent 5 mm.data suggest a critical proactive role for the lymphocyte in
formation of the endothelial invaginations.
Given the size, dynamics, and clustered patterns of the
endothelial cell invaginations, we hypothesized that they
might be formed in response to podosome protrusions
generated by leukocytes. After a brief incubation of
lymphocytes with endothelium, samples were fixed and
stained for ICAM-1 and F-actin, along with lymphocyte
b2-integrin (aLb2; LFA-1) or talin-1. High-resolution confo-788 Immunity 26, 784–797, June 2007 ª2007 Elsevier Inc.cal imaging revealed the existence of clusters of ventral
leukocyte protrusions, each 0.2–1 mm in diameter, with
LFA-1 (Figures 4A and 4B)- and talin-1 (Figure 4C)-rich
outer rings and F-actin-rich inner cores (Figures 4A–4C).
These features support the designation of the lymphocyte
protrusions as podosomes. We term the corresponding
ICAM-1-rich invaginations on the endothelial surface
‘‘podoprints.’’ Podoprints were of slightly greater diameter
than their cognate podosomes (Figures 4A and 4B).
Immunity
Podosomes Initiate Transcellular DiapedesisFigure 4. Endothelial Invaginations Result from Podosome-
like Protrusive Structures
(A–C) Confocal imaging of lymphocyte-endothelial interactions.
Lymphocytes were incubated with TNF-a-activated HDMVEC forWe further examined lymphocyte actin dynamics during
podosome and podoprint formation in live cells (Figure 4D
and Movie S9). GFP-actin expressed in transiently trans-
fected primary human lymphocytes formed dynamic
puncta similar to those typically observed for podosomes
(Evans et al., 2003) that were spatially and temporally
correlated with the formation of podoprints on the endo-
thelium (Figure 4D and Movie S9).
In addition to the IL-2-cultured effector type lympho-
cytes used throughout this study, we also examined
IL-15-cultured memory type (Weninger et al., 2001) lym-
phocytes. These formed podoprints, podosomes, and
transcellular pores through TNF-a-activated endothelium
with roughly similar efficiency as IL-2-cultured lympho-
cytes (data not shown). Alternatively, freshly isolated
peripheral blood lymphocytes (PBLs) underwent little
adhesion, migration, or diapedesis in this inflamed endo-
thelial model, which correlated with infrequent initiation
of podosomes (<5% of PBLs) or transcellular pores
(<1% of PBLs) (data not shown) and the predominance
of naive lymphocytes, which fail to emigrate at sites of
inflammation in vivo (Weninger et al., 2001).
Podosomes have not previously been observed in
lymphocytes but have been widely observed in leukocytes
of myeloid lineage (Buccione et al., 2004; Linder and
Aepfelbacher, 2003). Primary human monocytes, a repre-
sentative myeloid lineage cell, induced podoprints that
were essentially identical to those induced by lympho-
cytes (Figure S2B).
Lymphocyte Podosomes Extend and Invade
into the Endothelial Cytoplasm
Transmission electron microscopy (TEM) was used to
further investigate the lymphocyte-protrusive structures
and their relation to transcellular diapedesis. Consistent
with fluorescence imaging data, TEM revealed lymphocytes
5 min followed by fixation, staining for F-actin (blue), leukocyte b2
integrin (red), endothelial ICAM-1 (green in [A] and [B]), or talin-1 (green
in [C]), and confocal microscopy described in Experimental Proce-
dures. Images are representative Z-stack projections of confocal sec-
tions near the plane of the leukocyte-endothelial interaction interface.
(A) A merged image of b2 integrin, F-actin, and ICAM-1 is shown in
which two adjacent lymphocytes, one spread and somewhat dumb-
bell-shaped (lower left) and one rounded (upper right), adhere to the
surface of the endothelium.
(B) An expanded view of the boxed region in (A) is shown as both
separate and merged fluorescent channels.
(C) In a separate experiment, samples were stained for b2 integrin,
F-actin, and talin-1.
(D) Live-cell imaging of lymphocyte actin. Lymphocytes transiently
expressing GFP-actin were incubated with activated HDMVEC
expressing memb-RFP and subjected to live-cell imaging. Left and
right panels depict a lymphocyte at time points before (relative time
point = 0 s) and after (relative time point = 266 s), respectively, endo-
thelial podoprint formation. Memb-RFP, GFP-actin, and merged
images are as indicated. Arrows indicate the appearance of podo-
some-like (Evans et al., 2003) actin puncta in lymphocytes that are
centered within the memb-RFP rings of the endothelial podoprints.
Note the distinctly green areas (actin) evident at the center of each
ring. See corresponding Movie S8. Scale bars represent 5 mm.Immunity 26, 784–797, June 2007 ª2007 Elsevier Inc. 789
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dothelial cells (Figure 5). Endothelial invaginations were
not observed in the absence of lymphocyte protrusions.
In many cases, the lymphocyte protrusions and endothe-
lial cell invaginations extended deeply into the endothelial
cytoplasm (Figure 5A, see ‘‘I’’). These often extended to
a depth in which the apical endothelial plasma membrane
was brought into close proximity to the basal aspect
of the endothelium (Figure 5B, see ‘‘I1–I3’’). We also
observed lymphocytes that had formally breached the
endothelium and were at various stages of transcellular
migration at sites distant from intact interendothelial cell
junctions (Figure S3). In addition, podosomes were seen
that pressed against the endothelial cell nucleus; how-
ever, these were invariably shallow and never provided
a pathway for lymphocyte transmigration (Figures 5C
and 5D).
For 143 lymphocyte protrusions from randomly
selected sections, dimensions were determined in the
y axis normal to the endothelial monolayer and in the
xz plane of the monolayer. The average width along
the x axis was 344 ± 13 nm. For several podosomes, we
also estimated the width in the z axis by determining the
minimal number of 90 nm-thick serial sections that con-
tained the entire podosome. The average z:x ratio was
1.2 ± 0.06 (n = 8), demonstrating that these structures
were basically symmetrical in agreement with the confocal
analysis above. The depth of protrusions into the endothe-
lium in the y axis was 482 ± 29 nm (n = 143). Thus, these
structures were consistent with podosomes (width and
depth both 200–500 nm [Buccione et al., 2004; Linder
and Aepfelbacher, 2003]).
However, diameters ranged from 94 to 1046 nm and
depths ranged from 81 to 2145 nm. Thus, many of the pro-
trusions exceeded typical size criteria for podosomes and
exhibited widths and, particularly, depths that were more
consistent with invadopodia (Figures 5A and 5B, see ‘‘I’’
and ‘‘I1–I3,’’ respectively; Buccione et al., 2004; Linder
and Aepfelbacher, 2003). We term these extended protru-
sions ‘‘invasive podosomes.’’ Importantly, the sizes were
continuously distributed between the extremes, rather
than bimodally (Figure S4), consistent with a continuum
of related protrusive structures rather than the coexis-
tence of categorically distinct ones.
To assess the physiologic relevance of these structures,
we examined leukocyte-endothelial interactions in two
distinct settings in vivo. TEM of inflamed vessels in
a guinea pig model of dermatitis demonstrated both lym-
phocytes (Figure 5E) and basophils (Figure 5F) bearing
multiple ventral podosomes and invasive podosomes
(essentially identical to those seen in vitro) that protruded
into endothelial invaginations. Similar observations were
made for murine mononuclear cells bound to tumor-
associated vessels (Figure S5). These results demonstrate
that the podosomes and invasive podosomes form in vivo
and in the context of shear flow. We further confirmed this
latter point by assessing lymphocyte podoprint formation
on HLMVECs in the presence of 2 dyne/cm2 laminar shear
flow in vitro. In this setting, the overall efficiency and790 Immunity 26, 784–797, June 2007 ª2007 Elsevier Inc.dynamics of podosome, podoprint, and transcellular
pore formation were similar to those seen under static
conditions (data not shown).
Podosomes Are Required for Efficient Transcellular
Pore Formation
The regulatory protein WASP has been shown to be criti-
cal for podosome formation (Calle et al., 2004; Linder and
Aepfelbacher, 2003). To investigate the role of WASP in
our system, we obtained lymphocytes from WAS and
XLT (X-linked thrombocytopenia) patients bearing the
WASP-destabilizing mutations W64R or P58A, respec-
tively. Immunoblotting demonstrated that WASP expres-
sion was either undetectable (W64R) or 10% (P58A)
the amount of control lymphocytes (Figure 6A). Live-cell
imaging with these lymphocytes demonstrated that
spreading and lateral migration on endothelium was gen-
erally normal (Movie S10). Indeed, lateral migration veloc-
ities for W64R (4.9 ± 0.3 mm/min, n = 69) and P58A (5.1 ±
0.5 mm/min, n = 21) lymphocytes were indistinguishable
from control (4.6 ± 0.4 mm/min, n = 28). In contrast, how-
ever, podoprint induction (a readout for podosome forma-
tion) was reduced to 25% of control (Figure 6B and Movie
S10). In addition, dynamic imaging suggested a selective
reduction in transcellular diapedesis (Movie S10). This
phenotype was quantified through fixed-cell imaging
experiments (Figures 6C and 6D). Whereas paracellular
diapedesis was similar to control (Figure 6C), transcellular
diapedesis was reduced by more than 80% in WASP-
deficient lymphocytes (Figure 6D).
Podosomes are reported to depend strongly on Src
kinase activity (Buccione et al., 2004; Linder and
Aepfelbacher, 2003). Thus, we pretreated lymphocytes
with Src inhibitor PP2 or vehicle (DMSO, control) and
conducted dynamic and fixed-cell analysis similar to
those described above for WASP-deficient cells. Live-
cell imaging demonstrated that the PP2-treated lym-
phocytes spread, polarized, and migrated laterally on
endothelium with velocities (4.6 ± 0.5 mm/min, n = 14)
similar to control (5.2 ± 0.5 mm/min, n = 24). However,
the Src-inhibited lymphocytes displayed significantly
reduced podoprint formation (p = 0.0005) (Figure 6E)
that correlated with a selective decrease in transcellular
diapedesis (Figures 6F and 6G). Together, the results with
WASP-deficient and Src-inhibited lymphocytes demon-
strate the importance of leukocyte podosomes in transcel-
lular pore formation.
Regulated Membrane Fusion in Endothelial
Cells Is Required for Efficient Transcellular
Pore Formation
During both in vitro and in vivo ultrastructure analysis, we
noted an enrichment of endothelial vesicles and VVOs
(vesiculo-vacuolar organelles) (Feng et al., 2002) immedi-
ately adjacent to sites of podosome protrusion (Figure 5
and Figure S5). Quantitative analysis revealed a 4-fold
increase in total vesicle density in cultured endothelium
within 500 nm of podosomes, compared to endothe-
lium without attached lymphocytes or with attached
Immunity
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over, the density of vesicles and VVOs that were fused
or docked to the endothelial cell plasma membrane was
also increased by 4-fold at these locations (Figure 7A).
These data suggest that lymphocyte podosomes trigger
local recruitment and fusion of endothelial vesicles with
the plasma membrane.
We sought to identify and monitor these vesicles via
live-cell fluorescence imaging during podoprint formation.
However, markers for caveolae (cav1-GFP) (Movie S11),
endosomes (pACGFP-Endo) (not shown), and lysosomes
(LAMP1-GFP; Lyso-Tracker Green) (not shown) were not
enriched adjacent to podoprints, as quantified by Pear-
son’s correlation analysis of the distribution of these
markers relative to memb-RFP (Figure 7B). In contrast,
we found that two important fusogenic proteins in endo-
thelium, the SNAREs VAMP2 (p < 0.0001) and VAMP3
(p < 0.0001), became significantly enriched in podoprints
and early-stage transcellular pores, exhibiting large
increases in Pearson’s coefficients (Figures 7B and 7C
and Movie S12).
To investigate whether fusion activity is important for
transcellular pore formation, we blocked function of the
NSF-, SNAP-, and SNARE-complex in endothelium either
by chelating intracellular calcium with BAPTA-AM or by
inactivating NSF (NEM-sensitive factor) with N-ethyl
maleimide (NEM). Through live-cell imaging, we observed
that whereas podoprints were essentially normal, trans-
cellular pore formation was reduced in each of these
settings (not shown). This was quantified by fixed-cell
imaging experiments; these showed significant reduc-
tions in transcellular pore formation of 87% (p < 0.0001)
and 72% (p = 0.0004) by BAPTA and NEM treatments,
respectively (Figure 7E). Paracellular diapedesis was
only modestly reduced (by10%) by BAPTA in this setting
and was actually increased by NEM (Figure 7D), correlat-
ing with partial junction disruption effect by NEM (not
shown).
DISCUSSION
Crossing endothelial barriers is a critical requirement for
leukocyte trafficking and immune system function. Our re-
sults here, coupled with recent in vitro (Carman and
Springer, 2004; Cinamon et al., 2004; Millan et al., 2006;
Nieminen et al., 2006; Yang et al., 2005) and previous
in vivo (Feng et al., 1998; Greenwood et al., 1994; Lossinsky
and Shivers, 2004; Marchesi and Gowans, 1963; Wolburg
et al., 2005) investigations, demonstrate that transcellular
diapedesis is a quantitatively important contributor to
overall physiologic leukocyte trafficking. Lossinsky and
Shivers (2004) have proposed that diapedesis occurs
through the ‘‘path of least resistance,’’ an idea that was re-
cently supported by in vivo studies (Wang et al., 2006). For
transcellular diapedesis in particular, the means by which
leukocytes identify sites permissive to transcellular pore
formation have remained mysterious. The dynamic podo-
some- and invasive podosome-mediated protrusive be-
havior uncovered in the current study provides a mecha-nism for leukocytes to both discover and exploit such
pathways.
Through combined fluorescence and ultrastructure im-
aging studies, we discovered highly dynamic leukocyte
protrusions that form against the endothelial surface.
Based on their architecture, dynamics, and WASP and
Src dependence, these protrusions were determined to
represent podosomes and extended ‘‘invasive podo-
somes.’’ These were formed by lymphocytes, monocytes,
and basophils and observed both in vitro and several set-
tings in vivo. Most importantly, transcellular diapedesis,
but not paracellular diapedesis or lateral migration, was
found to be highly dependent on podosomes and invasive
podosomes.
The dozens of podosome protrusions that form rapidly
during lateral migration seem to provide an efficient
means for leukocytes to probe or palpate the local surface
resistance of the endothelium (Figure S6). In response to
podosomes, endothelial cell-surface invaginations, i.e.,
podoprints, were formed, which displaced and distorted
the cytoplasm, actin filaments, microtubules, and endo-
plasmic reticulum to varying degrees. Shallow podo-
somes and podoprints were also frequently observed to
encounter the endothelial nucleus, but with modest distor-
tion and never transcellular pore formation at these sites
(see model, Figure S6). We presume that the nuclear
envelope and its underlying lamina provide too great
a resistance for deeper penetration.
The finding of podoprints over nuclei suggests that
leukocytes do not know a priori that they cannot diape-
dese directly through the nucleus, but must discover
a route through trial and error. Even in nonnuclear areas,
the vast majority of podosomes were inserted less than
600 nm into the endothelium (half of the total average en-
dothelial cell thickness) and were rapidly retracted after
10–30 s without transcellular pore formation (Figure S6).
This suggests that endothelial locations permissive for
deeper protrusion and transcellular diapedesis are limit-
ing. We anticipate that the efficiency of transcellular dia-
pedesis is governed by the sum local resistances provided
by endothelial organelles including the plasma membrane,
nucleus, cytoskeleton, and endoplasmic reticulum. We
propose that podosome-mediated palpation during lateral
migration provides leukocytes with a stochastic mecha-
nism to efficiently identify locations of relatively low total
endothelial resistance (Figure S6). When such locations
are encountered, podosomes are able to progressively
extend (becoming invasive podosomes) all the way to
the basal endothelial surface, resulting in transcellular
pore formation (Figure S6).
Our studies here demonstrate a distinct proactive role
for the endothelium in locally modulating permissiveness
to leukocyte protrusions. We found that both plasma mem-
brane-fused vesicles and VVOs and fusogenic proteins
(i.e., the SNAREs VAMP2 and 3) were substantially
enriched at endothelial sites of podosome protrusion. Fur-
thermore, the efficiency of transcellular pore formation was
attenuated by endothelial treatments (i.e., BAPTA and
NEM) that inhibit SNARE fusogenic activity. We envisionImmunity 26, 784–797, June 2007 ª2007 Elsevier Inc. 791
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calcium fluxes initiated through endothelial adhesion re-
ceptors or stretch-activated ion channels) that trigger
site-specific SNARE complex-mediated vesicle and VVO
fusion. Such vesicle fusion could serve to lower local sur-
face tension, by providing additional plasma-membrane
Figure 5. In Vitro and In Vivo Ultrastructure of Lymphocyte Podosomes and Invasive Podosomes
(A–D) Podosomes in vitro. Lymphocytes migrating on TNF-a-activated HDMVEC were fixed after a 5 min coincubation and processed for transmis-
sion EM as described in Experimental Procedures.
(A) A lymphocyte extends three shallow (0.3 mm) podosomes (‘‘P1–P3’’) and one deep (1.5 mm) invasive podosome (‘‘I’’) into endothelial invagi-
nations. Inset is an expanded view of podosome ‘‘P2.’’
(B) A lymphocyte extends three shallow (0.2–0.5 mm) podosomes (‘‘P1–P3’’) and three deep (1.5 mm) invasive podosomes (‘‘I1–I3’’) that span to
nearly the basal surface.
(C and D) Shallow lymphocyte podosomes ‘‘P1–P6’’ that have formed directly over the endothelial cell nucleus. ‘‘P1’’ shows the apical plasma
membrane nearly in contact with the nuclear envelope and ‘‘P6’’ shows it mildly indenting, but not invaginating, the nucleus.
(E and F) Podosomes in vivo. A guinea pig model of dermatitis was prepared and processed for TEM as described in Experimental Procedures. The
representative lymphocyte (E) and basophil (F) are from an extensive analysis, including four different experiments and examination of at least 100
distinct lymphocytes and at least 100 distinct basophils. More than half of all both lymphocytes and basophils exhibited at least one podosome in any
given section.
(E) Lymphocyte podosomes (‘‘P1–P3;’’ 0.2–0.5 mm) and an invasive podosome (‘‘I;’’ 0.8 mm) project into the endothelial surface of an inflamed
vessel. Note that ‘‘I’’ has traversed the entire depth of the endothelial cell and placed the luminal and abluminal membranes into extremely close
apposition.
(F) Multiple basophil podosomes (‘‘P1–P8;’’ 0.2–0.5 mm) protrude into the endothelial surface.
In all panels, leukocytes are indicated by a 5% opacity red overlay. In all panels, arrows indicate endothelial vesicles and VVOs, both apparently free in
the cytoplasm and fused or docked to the plasma membrane, enriched near leukocyte protrusions. Scale bars represent 500 nm in (A)–(C), (E), and (F)
and 100 nm in insert in (A) and (D).
Figure 6. Podosomes and Transcellular Diapedesis Are Dependent on Lymphocyte Src and WASP Activity
(A) Lysates from IL-2-cultured control and WASP-deficient (P58A and W64R) lymphocytes were immunoblotted for WASP and actin as described
(Jin et al., 2004).
(B) Podosome formation by WASP-deficient lymphocytes. Control, P58A, and W64R lymphocytes were incubated with TNF-a-activated HLMVEC
transiently transfected with memb-YFP and subjected to live-cell dynamic imaging. As a readout for podosome formation, podoprint indices were
quantified as described in Experimental Procedures. Values are mean ± SEM of measurements obtained from at least 40 lymphocytes. See corre-
sponding Movie S10.
(C and D) Para- and transcellular diapedesis in WAS lymphocytes. Control, P58A, and W64R lymphocytes were incubated with activated HLMVEC for
5 min and then fixed, stained, and scored for para- and transcellular diapedesis.
(C) Paracellular diapedesis by P58A and W64R lymphocytes were expressed as a percentage of the control value (36.5% ± 1.7% of total cells).
(D) Transcellular diapedesis by P58A and W64R lymphocytes were expressed as a percentage of the control value (22.5% ± 1.6% of total cells).
Values are mean of normalized values ± SEM for at least three separate experiments.
(E) Podoprint indices for lymphocytes pretreated with the Src inhibitor PP2 (1 mM, 60 min) or DMSO (control) were assessed as in (B).
(F and G) Para- and transcellular diapedesis in lymphocytes pretreated with PP2 (1 mM, 60 min) or DMSO (control) was as described in (C) and (D),
respectively. Control values for para- and transcellular diapedesis were 21.5% ± 2.6% (F) and 12.9% ± 1.6% (G) of total cells, respectively.Immunity 26, 784–797, June 2007 ª2007 Elsevier Inc. 793
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Podosomes Initiate Transcellular DiapedesisFigure 7. Endothelial Calcium- and SNARE-Mediated Membrane Fusion Is Required for Efficient Transcellular Diapedesis
(A) The density of both free (gray) and plasma-membrane-fused or docked (black) vesicles in HDMVEC was quantified in samples without () or with
(+) lymphocyte incubation and without () or with (+) podosomes, as described in Experimental Procedures. Values are mean ± SEM for at least 74
linear segments, each 500 nm long.
(B) Pearson’s correlation for the distribution of caveolin-1-GFP (cav1), LAMP1-GFP (LAMP1), pACGFP-Endo (Endo), GFP, VAMP2-GFP (VAMP2), and
VAMP3-GFP (VAMP3) relative to memb-RFP, both prior to (gray bars) and during (black bars) podoprint formation, was quantified from live-cell
imaging experiments as described in Experimental Procedures. Values are mean ± SEM for at least five measurements.
(C) DIC, memb-RFP, VAMP3-GFP, and merged memb-RFP and VAMP3-GFP images are as indicated. Upper panels show a time point before
(relative time = 0 s) and lower panels show a time point after (relative time 290 s) the formation of memb-RFP podoprints. See corresponding Movie
S12. Scale bars represent 5 mm.
(D and E) Activated HLMVEC were pretreated with BAPTA-AM (20 mM, 60 min), NEM (300 mM, 5 min), or DMSO (control) and then incubated with
lymphocytes for 5 min followed by fixation, staining, and scoring. Control values for para- and transcellular diapedesis were 29% ± 1.2% (D) and
14.9% ± 1.8% (E) of total cells, respectively.surface area and thereby allow invasive podosomes to
probe progressively deeper.
In vivo ultrastructure studies here in two distinct settings
demonstrated physiologic relevance for both the leuko-
cyte palpation behavior and the resulting endothelial ves-
icle enrichment. A re-examination of the existing literature
provides further support for this. Indeed, though referred
to variously as ‘‘processes,’’ ‘‘filopodia-like structures,’’
and ‘‘pseudopods,’’ ultrastructurally defined protrusions
remarkably similar to the podosomes and invasive podo-
somes characterized in the current study have been
demonstrated in vivo to be formed by lymphocytes (Fujita
et al., 1991; Lossinsky and Shivers, 2004; Olah and Glick,
1985; Raine et al., 1990; Wolburg et al., 2005; Wolose-
wick, 1984), monocytes (Greenwood et al., 1994), and
tumor cells (De Bruyn et al., 1989) during transcellular
diapedesis across a variety of vascular and lymphatic794 Immunity 26, 784–797, June 2007 ª2007 Elsevier Inc.endothelia, often in association with visible endothelial
vesicle enrichment.
Beyond vascular and lymphatic endothelium, the act of
palpating in order to identify the ‘‘path of least resistance’’
could be important for other substrates encountered by
leukocytes during trafficking. For example, it was recently
demonstrated that neutrophil extravasation in vivo occurs
preferentially near pre-existing attenuations in the base-
ment membrane, suggesting that leukocytes possess
mechanisms to identify weak points in the matrix (Wang
et al., 2006). It has also been demonstrated that neutro-
phils are capable of transcellular diapedesis through the
pericytes underlying the vascular endothelium (Feng
et al., 1998). Moreover, leukocytes are known to cross
the intestinal epithelium by yet incompletely understood
mechanisms (Zen and Parkos, 2003). Interestingly, we
found here that lymphocytes readily formed podosomes
Immunity
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K1 expressing ICAM-1-GFP. Thus, podosome-dependent
leukocyte-protrusive behavior might indeed have broad
roles in leukocyte trafficking.
Our studies point to important new ideas regarding
the function of podosomes and their relation to invado-
podia, a recent subject of intense investigation. The
structures formally defined as ‘‘invadopodia’’ have been
demonstrated only in transformed cells where they func-
tion to confer invasiveness, i.e., the ability to cross tissue
barriers. Functions for podosomes have remained
unclear. To our knowledge, the functional role of leuko-
cyte podosomes has not previously been studied in the
context of the endothelium, a physiologic and ‘‘soft’’
substrate. Instead, the vast majority of studies have em-
ployed solid glass and plastic substrates, which would
likely frustrate the formation of extended invasive podo-
somes and mask the protrusive and invasive functions
(Yamaguchi et al., 2005b) that we have described here.
Moreover, assays directly implicating podosomes (and
related signaling activities including WASP and Src) in
leukocyte locomotion and lateral migration have been
performed on glass and plastic substrates with inclusion
of only a single chemoattractant. This contrasts with the
robust and physiologic substrate provided by the acti-
vated endothelium on which lymphocyte lateral migration
was independent of podosomes. We found, in the phys-
iologic setting of leukocyte-endothelial interaction, the
dominant function of podosomes was in protrusion and
invasion, functions akin to those ascribed to tumor-cell
invadopodia.
A precursor role of podosomes relative to invadopodia
has been hypothesized (Buccione et al., 2004; Linder
and Aepfelbacher, 2003; Yamaguchi et al., 2005a) but
remains controversial. On the ‘‘soft’’ endothelial substrate,
lymphocyte podosomes were free, at permissive loca-
tions, to progressively extend to invadopodia-like depths
(several microns) as they transition to ‘‘invasive podo-
somes.’’ These structures served an unambiguously inva-
sive function; indeed, the act of passing directly through
another cell would seem to be the ultimate act of invasive-
ness. Leukocyte podosomes have also recently been
shown to possess invadopodia-like matrix-degrading
capabilities (Buccione et al., 2004; Linder and Aepfel-
bacher, 2003). These observations suggest that leuko-
cytes are capable of expressing a continuum of related
podosomes and invadopodia-like structures.
Thus, we propose that (with the exception of osteo-
clasts, which have the distinction of interacting with
a physiologic solid substrate, i.e., bone [Buccione et al.,
2004; Linder and Aepfelbacher, 2003]) podosomes are
probing or palpating organelles, uniquely designed for
‘‘path finding,’’ rather than locomotion per se, during the
process of tissue-barrier crossing and invasion. Tumor-
cell invadopodia likely represent the pathologic subver-
sion of the physiologic invasive podosome.
These findings add to our understanding of basic mech-
anisms for leukocyte trafficking. Future investigation of
how leukocyte podosomes are influenced by diversein vivo settings may provide even greater understanding
of both normal and pathologic immune cell trafficking.
EXPERIMENTAL PROCEDURES
Antibodies and Reagents
See Supplemental Experimental Procedures.
Cells and Cell Culture
Studies of human blood were approved by the institutional review
board at the CBRI, Harvard Medical School. Written informed consent
was obtained from all the subjects. Animal studies were conducted
under protocols approved by the Committee on Use and Care of
Animals at BIDMC, Harvard Medical School. Preparation of mitogen-
activated, IL-2-cultured primary human lymphocytes (model effector
type lymphocytes [Weninger et al., 2001]) was as described (Carman
and Springer, 2004). Resulting cells were 97% CD3+, CD56,
50% CD4+, and 50% CD8+. Freshly isolated human PBL and
monocytes were prepared as described (Carman et al., 2003; Carman
and Springer, 2004). IL-2-cultured lymphocytes, from patients with
WASP-destabilizing mutations (W64R or P58T) and healthy volunteers
(control), were prepared and assessed by immunoblotting as
described (Jin et al., 2004). The W64R patient presented a classic
WAS phenotype (clinical score of 4), and the P58A patient presented
a milder phenotype (clinical score of 2) with features of XLT (Jin
et al., 2004). Stably transfected K562 cells expressing LFA-1 and
CHO-K1 cells expressing ICAM-1-GFP were described (Carman
et al., 2003). HUVEC, HDMVEC, and HLMVEC were purchased from
Cambrex (East Rutherford, NJ) and cultured on fibronectin (20 mg/
ml)-coated substrates in either EGM-2 (for HUVEC) or EGM-2MV
(HDMVEC and HLMVEC) media (Cambrex). In addition, HDMVEC
(HDMVEC*) and lymphatic ECs (Lymph*) were isolated from fresh
neonatal foreskins (Richard et al., 1998). EC and lymphocyte transient
transfection was by Amaxa Nucleofection according to the manufac-
turer’s instructions (Amaxa Inc., Gaithersburg, MD). pAcGFP1-Endo,
membrane-YFP, monomeric-DSRed (RFP), pEGFP-tubulin, and
pEGFP-actin plasmids were purchased from Clontech (Mountain
View, CA). Memb-RFP was generated by overlap-extension PCR to
add an N-terminal palmitoylation sequence (from membrane-YFP) to
monomeric-DSRed. Other DNA constructs were kind gifts from
T. Kirchhausen (LAMP1-GFP, CBR Institute for Biomedical Research),
M. Lisanti (Caveolin-1-GFP, Thomas Jefferson University), E. Masuda
(VAMP2-GFP, Rigel Pharmaceuticals, San Francisco, CA), and
W.S. Trimble (VAMP3-GFP, University of Toronto).
Lymphocyte Diapedesis
ECs were plated at 90% confluency on fibronectin (20 mg/ml)-coated
glass surfaces and cultured for 48–72 hr and then activated for 12 hr
with TNF-a (50 ng/ml) before use. Where indicated, ECs were also
preincubated with BAPTA-AM (20 mM, 1 hr), NEM (300 mM, 5 min), or
equal dilutions of vehicle (DMSO). In addition, for specified experi-
ments, ECs were prelabeled with either Endo- or Lyso-Tracker Green
(100 nM for 30 min at 37C). ECs were washed five times prior to
addition of lymphocytes with Hank’s balanced salt solution supple-
mented with 20 mM HEPES (pH 7.2) and 1% human serum albumin
(Buffer A). Lymphocytes were washed and resuspended in Buffer A
and then added to EC monolayers and incubated at 37C for the
indicated times. Where indicated, lymphocytes were preincubated
with the Src-inhibitor PP2 (1 mM, for 60 min) or an equal dilution of
vehicle (DMSO).
Fixed-Cell Imaging
Samples were fixed and stained for b2 (LFA1/7-488, -Cy3, or -Cy5),
ICAM-1 (IC1/11-488 or IC1/11-Cy3), VE-cadherin (55-7H1-488, -Cy3,
or -Cy5), PECAM-1 (9G11-Cy3), JAM-1 (polyclonal anti-JAM-1-488),
talin-1 (polyclonal anti-talin-1 followed by goat anti-rabbit-488), and
F-actin (phalloidin-488, -546, or -647) as described (Carman andImmunity 26, 784–797, June 2007 ª2007 Elsevier Inc. 795
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determined from the relative distribution (assessed by confocal
microscopy) of ICAM-1 and LFA-1 and VE-cadherin, PECAM-1,
JAM-1 or actin fluorescence in both the x-y and z dimensions (Carman
and Springer, 2004). Diapedesis adjacent to endothelial cell-cell
junctions was scored as paracellular; diapedesis where no part of
the transmigration passage was within 1 mm of a junction was scored
as transcellular.
Live-Cell Imaging
For live-cell imaging, ECs growth on Bioptechs delta-T chambers were
maintained at 37C in Buffer-A before and during addition of
leukocytes. DIC and epifluorescence images were acquired at
intervals of 10–15 s as indicated for durations of 20 min. Migrating
lymphocytes were determined to be above (bright edges) or below
(dark edges) the endothelium based on their diffractive properties in
DIC. Initiation of diapedesis was determined by the appearance, under
bound lymphocytes, of an endothelial region in which the fluorescent
membrane reporter was completely displaced, forming a ‘‘black
spot.’’ This readout was validated by confocal microscopy as
described (Carman and Springer, 2004). Endothelial junctions could
readily be seen by DIC. However, determination of transcellular
diapedesis in most cases was simplified by imaging individual
reporter-positive EC transfectants surrounded by reporter-negative
ECs. Unambiguous transcellular pores could be seen as dark spots
formed >3 mm away from the edge of these individual cells (the criteria
of 3 mm was used here, rather than 1 mm used above for confocal
analysis, to account for the relative decrease in resolution with this
technique). Details for analysis of live-cell imaging are provided in
Supplemental Experimental Procedures.
Light-Microscopy Image Acquisition and Processing
Wide-field DIC and epifluorescence imaging were on a Zeiss Axiovert
S200 epifluorescence microscope (Germany), with a 633 oil objective
and a Hamamatsu Orca CCD (Japan). Confocal imaging was
performed with a Biorad Radiance 2000 laser-scanning confocal
system on an Olympus BX50BWI microscope with a 1003 water-
dipping objective. For serial Z-stacks, the Z-step was between 0.1
and 0.3 mm. Pearson’s analysis was conducted with Volocity 3.6.1
software (Improvision). Other analysis was with Openlab software
(Improvision). Images were exported to Adobe Photoshop or Apple
Quicktime software for preparation of final images or videos,
respectively.
Transmission Electron Microscopy
TNF-a-activated HDMVEC grown on fibronectin-coated coverglass,
with or without lymphocyte coincubation (as indicated) were fixed
with 2.5% glutaraldehyde and 2% paraformaldehyde in 1.0 M sodium
cacodylate buffer (pH 7.4), for 2 hr, postfixed in 1.5% sym-collidine-
buffered OsO4 for 1 hr, stained en bloc with uranyl acetate, dehydrated
in a series are graded alcohols, and embedded in Eponate. The cover-
glass was then separated from the basal aspect of the endothelium by
brief treatment with liquid nitrogen (a step that causes mild disruption
to the basal plasma membrane, lowering its contrast in EM), and the
samples were then re-embedded with the monolayer parallel to the
long axis of the embedding block. Thin Eponate sections of 90 nm,
cut perpendicular to the long axis of the block (and to the plane of
the monolayer), were visualized with a Philips CM-10 electron micro-
scope at 80 kV. Preparation of Hartley guinea pigs sensitized for cuta-
neous basophil hypersensitivity reactions (Dvorak and Dvorak, 1993)
and solid MOT tumors grown in C3Heb/FeJ mice (Nagy et al., 1995)
were described. Tissue was processed for TEM as described (Feng
et al., 2002). Details for the quantitation of ultrastructure are provided
in Supplemental Experimental Procedures.
Supplemental Data
Six figures, twelve movies, and Experimental Procedures are available
at http://www.immunity.com/cgi/content/full/26/6/784/DC1/.796 Immunity 26, 784–797, June 2007 ª2007 Elsevier Inc.ACKNOWLEDGMENTS
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